In pregnant women, severe Clostridium difficile-associated disease may be an emerging threat.
In pregnant women, severe Clostridium difficile-associated disease may be an emerging threat, according to a report published in the June issue of the American Journal of Obstetrics and Gynecology.
Nadine G. Rouphael, MD, of the Centers for Disease Control and Prevention in Atlanta, and colleagues collected clinical and pathology data on severe cases and surveyed 798 infectious disease consultants in the Emerging Infections Network, of whom 419 (52%) responded.
The researchers collected information on 10 severe cases, including three maternal deaths and three stillbirths. In two cases, the epidemic C difficile strain was identified. In their survey, 37 infectious disease consultants cited a total of 55 cases and 21 complications, most of which occurred during the postpartum period.
Rouphael NG, O'Donnell JA, Bhatnagar J, et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obstet Gynecol. 2008:198:635.e1-635.e6.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More